Gregory J Keir
Overview
Explore the profile of Gregory J Keir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
789
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li R, Tan D, Tedja C, Cooper W, Jo H, Grainge C, et al.
Respirology
. 2025 Feb;
PMID: 39919729
Background And Objective: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a poor prognosis. Antifibrotics slow the decline of pulmonary function after 12-months, but limited studies have...
2.
Li A, Teoh A, Troy L, Glaspole I, Wilsher M, de Boer S, et al.
Thorax
. 2024 Sep;
79(11):1024-1032.
PMID: 39317451
Background: Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations...
3.
Samaranayake C, Upham J, Tran K, Howard L, Nguyen S, Lwin M, et al.
BMJ Open Respir Res
. 2023 Jul;
10(1).
PMID: 37491130
Background: Data on right ventricular (RV) exercise adaptation following acute intermediate and high-risk pulmonary embolism (PE) remain limited. This study aimed to evaluate the symptom burden, RV functional recovery during...
4.
Assayag D, Adegunsoye A, Sheehy R, Morisset J, Khalil N, Johannson K, et al.
Chest
. 2023 Jan;
163(5):1156-1165.
PMID: 36621759
Background: Biological sex, gender, and race are important considerations in patients with interstitial lung diseases (ILDs). Research Question: Does a patient's sex assigned at birth, and race, influence ILD treatment...
5.
Bell P, Sheehy R, Droney L, Prain K, Wong R, Keir G
Respirol Case Rep
. 2022 Oct;
10(11):e01058.
PMID: 36284753
Anti-Neutrophil Cytoplasmic Antibody associated Vasculitides (AAV) comprise a rare group of disorders in which respiratory tract involvement is variable and often severe. The rarity and heterogeneity of AAV makes this...
6.
Humphries S, Mackintosh J, Jo H, Walsh S, Silva M, Calandriello L, et al.
Respirology
. 2022 Jul;
27(12):1045-1053.
PMID: 35875881
Background And Objective: Prediction of disease course in patients with progressive pulmonary fibrosis remains challenging. The purpose of this study was to assess the prognostic value of lung fibrosis extent...
7.
8.
Clynick B, Corte T, Jo H, Stewart I, Glaspole I, Grainge C, et al.
Eur Respir J
. 2021 Oct;
59(3).
PMID: 34675050
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which circulatory biomarkers have the potential for guiding management in clinical practice. We assessed the prognostic role of serum...
9.
Jee A, Sheehy R, Hopkins P, Corte T, Grainge C, Troy L, et al.
Respirology
. 2020 Nov;
26(1):23-51.
PMID: 33233015
Pulmonary complications in CTD are common and can involve the interstitium, airways, pleura and pulmonary vasculature. ILD can occur in all CTD (CTD-ILD), and may vary from limited, non-progressive lung...
10.
Clynick B, Jo H, Corte T, Glaspole I, Grainge C, Hopkins P, et al.
Eur Respir J
. 2020 May;
56(3).
PMID: 32381494
No abstract available.